NeuralCipher Research overview
The text below is the source article’s original abstract under a verified reuse license. cc by
ObjectiveTo isolate Parkinson's disease (PD)-specific gut dysbiosis from motility-related changes, this study compared the fecal microbiota of PD patients with constipation (PDC, n=20) against a functional constipation (FC, n=15) control group.MethodsHigh-throughput 16S rRNA gene sequencing and functional prediction were performed on fecal samples. Diversity metrics and taxonomic compositions were analyzed to identify PD-specific signatures.ResultsThe PDC group exhibited significantly higher microbial richness than the FC group (P = 0.01). Despite structural similarities driven by the shared constipation phenotype (ANOSIM R = 0.084), PDC was distinguished by specific compositional shifts, including the enrichment of Paraprevotella, Akkermansia, unclassified Ruminococcaceae, and Campylobacter. Functionally, the PDC microbiome showed significant deficits in tyrosine and glutathione metabolism pathways (PConclusionBy controlling for colonic transit time, this study identified specific microbial alterations and metabolic deficits in PD independent of constipation. These findings support a "gut-first" etiology linked to specific pathobionts and barrier compromise.
Scientific assessment
Research question
Assess the question within the original study’s scope.
Methods & sample
Check the source article for study design and sample details.
Key findings
An editorially approved findings summary is not yet published for this record.
Limitations
Generalizability, bias and clinical meaning require separate assessment.
Methods, samples and clinical conclusions are not inferred from bibliographic metadata.